Reported Jun 24, 2026 · Ongoing
directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2
Accriva Diagnostics, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Accriva Diagnostics, Inc. · 6260 Sequence Dr · San Diego, CA · 92121-4358
Is this the product you have?
- directCHECK ACT-LR whole blood quality control
- level 2 Model/Catalog NumberDCGLR-2
- Lot codes and dates
- Lot #:
- A6DLA001 Unique Device Identifier10711234170373
- Amount recalled
- 6060
Where it was sold
Why it was recalled
Assayed Whole blood control contains labeling with incorrect performance range.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Accriva Diagnostics, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.